Back to News
Market Impact: 0.35
Precigen, Inc. Reports Third Quarter 2026 Net Income of $35.8 million and PAPZIMEOS Net Revenue of $72.9 million
Source: Nasdaq
Corporate EarningsCompany FundamentalsHealthcare & Biotech
Precigen reported third-quarter 2026 PAPZIMEOS net product revenue of $72.9 million, up 37% quarter-over-quarter, and said it achieved positive cash flow during the quarter. The provided article text is truncated, so no further results or outlook are included.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment
PGEN0.65
More News
- Citizens raises Precigen stock price target to $12 on strong sales
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- Qualcomm slides 9% after earnings, leading post-election chip stock sell-off
- Costco is taking aim at its May record high — how it got here and where's it going
- Neocloud IREN says $4 billion in annualized revenue being delayed due to customer request